You are here:

aclidinium/formoterol fumarate dihydrate (Duaklir Genuair)

Advice

following a full submission:

aclidinium/formoterol fumarate dihydrate (Duaklir Genuair®) is accepted for use within NHS Scotland.

Indication under review: Maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease.

In two 24-week comparator- and placebo-controlled phase III studies, treatment with aclidinium/formoterol 340/12 microgram resulted in statistically significant improvements in FEV1 % predicted pre-dose (versus a LABA) and post-dose (versus a LAMA).

Drug Details

Drug Name: aclidinium/formoterol fumarate dihydrate (Duaklir Genuair)
SMC Drug ID: 1034/15
Manufacturer: Almirall Ltd
Indication: Maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease.
BNF Category:
Sub Category: 3.1 Bronchodilators
Submission Type: Full submission
Status: Accepted
Date Advice Published: 13 April 2015

Back